Prenatal transfer of anticardiolipin antibodies associated with fatal neonatal aortic thrombosis

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 45, Issue 2, 2005, Pages 175-176

  Tuohy, Jeremy ^a   Harrison, Andrew ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BERACTANT; BETAMETHASONE; CARDIOLIPIN ANTIBODY; DALTEPARIN; ENOXAPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; PROSTAGLANDIN E2; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; AORTA THROMBOSIS; ARTICLE; AUTOPSY; BREECH EXTRACTION; CASE REPORT; CESAREAN SECTION; DISEASE ASSOCIATION; FATALITY; FEMALE; FETUS; FETUS DEATH; FETUS WEIGHT; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; KIDNEY FAILURE; LABOR INDUCTION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN DEATH; NEWBORN DISEASE; PLACENTA DISORDER; PREECLAMPSIA; PRENATAL PERIOD; PRIORITY JOURNAL; VEIN THROMBOSIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; AORTIC DISEASES; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; THROMBOSIS;

EID: 17244376945     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2005.00371.x     Document Type: Article

References (13)

1. Mautone A, Giordano P, Montagna O, Quercia M, Altomare M, De Mattia D. Coagulation and fibrinolytic systems in the ill preterm newborn. Acta Paediatr. 1997; 86: 1100-4.
2. Chamley LW, McKay EJ, Pattison NS. Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis. Thromb Res. 1993; 71: 103-11.
3. Petaja J, Fernandez JA. Fellman V, Griffin JH. Upregulation of the antithrombotic protein C pathway at birth. Pediatr Hematol Oncol. 1998; 15: 489-9.
4. Bovill EG, Soll RF, Lynch M et al. Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate. Blood 1993; 81: 77-83.
5. Levy RA, Vilela VS, Cataldo MJ et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus, 2001; 10: 401-4.
6. Parke AL. West B. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J. Rheumatol. 1996; 23: 1715-18.
7. Parke AL, Rothfield NF. Antimalarial drugs in pregnancy - the North American experience. Lupus, 1996; 5 (Suppl. 1): S67-9.
8. Buchanan NM, Toubi E, Khamashta MA, Lima F, Kerslake S, Hughes GR. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 1996; 55: 486-8.
9. Warner AE. Early hydroxychloroquine macular toxicity. Arthritis Rheum, 2001; 44: 1959-61.
10. Klinger G, Morad Y, Westall CA. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet, 2001; 358 (9284): 813-4.
11. Johansen PB, Gran JT. Ototoxicity due to hydroxychloroquine: report of two cases. Clin Exp Rheumatol. 1998; 16: 472-4.
12. Costedoat-Chalumeau N, Amoura Z, Duhaut P et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum, 2003; 48: 3207-11.
13. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology, 2002; 41 924-9.